P1334 : A multicentre, randomised, open-label study comparing the efficacy and safety of two doses of Doxorubicin TransdrugTM to best standard of care in patients with advanced Hepatocellular Carcinoma (HCC) after sorafenib. The relive study

2015 ◽  
Vol 62 ◽  
pp. S856-S857 ◽  
Author(s):  
P. Merle ◽  
G. Pelletier ◽  
F. Habersetzer ◽  
G. Luca Frassineti ◽  
G.-P. Pageaux ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Standard Of Care ◽  
Advanced Hepatocellular Carcinoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population

Cancer ◽  
2008 ◽  
Vol 115 (2) ◽  
pp. 428-436 ◽  
Author(s):  
Thomas Yau ◽  
Pierre Chan ◽  
Kelvin K. Ng ◽  
Sin Ho Chok ◽  
Tan To Cheung ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B ◽  
Single Agent ◽  
Asian Population ◽  
Advanced Hepatocellular Carcinoma ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

2016 ◽  
Vol 11 (2) ◽  
pp. 199-208 ◽  
Author(s):  
Shi-Ming Lin ◽  
Sheng-Nan Lu ◽  
Ping-Tsung Chen ◽  
Long-Bin Jeng ◽  
Shinn-Cherng Chen ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Advanced Hepatocellular Carcinoma ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Phase Iv

scholarly journals A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

2018 ◽  
Vol 24 (2) ◽  
pp. 161 ◽  
Author(s):  
Ghassan K. Abou‐Alfa ◽  
Rebecca A. Miksad ◽  
Mohamedtaki A. Tejani ◽  
Stephen Williamson ◽  
Martin E. Gutierrez ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Advanced Hepatocellular Carcinoma ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Activin Receptor ◽  
Phase Ib ◽  
Receptor Like Kinase

Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

2012 ◽  
Vol 18 (7) ◽  
pp. 2090-2098 ◽  
Author(s):  
Richard S. Finn ◽  
Yoon-Koo Kang ◽  
Mary Mulcahy ◽  
Blase N. Polite ◽  
Ho Yeong Lim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Advanced Hepatocellular Carcinoma ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Open Label Study ◽  
Label Study ◽  
Line Therapy

scholarly journals Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

2011 ◽  
Vol 17 (7) ◽  
pp. 1973-1983 ◽  
Author(s):  
Joong-Won Park ◽  
Richard S. Finn ◽  
Jun Suk Kim ◽  
Mark Karwal ◽  
Ruby K. Li ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Advanced Hepatocellular Carcinoma ◽  
First Line ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document